Cerebral metabolism in major depressive disorder: A voxel-based meta-analysis of positron emission tomography studies

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Su, Liang ^a,b   Cai, Yiyun ^a,c   Xu, Yifeng ^c   Dutt, Anirban ^b   Shi, Shenxun ^a,c   Bramon, Elvira ^b,d  

^a FUDAN UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Activation likelihood estimation; Major depressive disorder; Meta analysis; Positron emission tomography

Indexed keywords

ARTICLE; BRAIN METABOLISM; CAUDATE NUCLEUS; CEREBELLUM VERMIS; CINGULATE GYRUS; ELECTROENCEPHALOGRAM; GLUCOSE METABOLISM; HUMAN; INSULA; LEFT LENTIFORM NUCLEUS PUTAMEN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PULVINAR; PUTAMEN; THALAMUS; WEB OF SCIENCE; BASAL GANGLION; BRAIN CORTEX; GLUCOSE BLOOD LEVEL; LIMBIC SYSTEM; MALE; METABOLISM; PROCEDURES; SCINTISCANNING; STATISTICAL MODEL;

FLUORODEOXYGLUCOSE F 18; GLUCOSE BLOOD LEVEL; RADIOPHARMACEUTICAL AGENT;

BASAL GANGLIA; BLOOD GLUCOSE; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; FLUORODEOXYGLUCOSE F18; HUMANS; LIKELIHOOD FUNCTIONS; LIMBIC SYSTEM; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THALAMUS;

EID: 84924184521     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0321-9     Document Type: Article

References (46)

1. Fusar-Poli P, Allen P, McGuire P: Neuroimaging studies of the early stages of psychosis: A critical review. Eur Psychiatr 2008, 23:237-244.
2. Linden DEJ: How psychotherapy changes the brain - the contribution of functional neuroimaging. Mol Psychiatry 2006, 11:528-538.
3. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
4. SU Liang SS-x, Yi-hui GUAN, Zuo C, Zhang M: Analysis of brain position emission tomography mapping in geriatric depression patients. Chin J Psychiatr 2006, 39:81-84.
5. Drevets WC: Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in brain research 2000, 126:413-431.
6. Dunn RT, Kimbrell TA, Ketter TA, Frye MA, Willis MW, Luckenbaugh DA, Post RM: Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 2002, 51:387-399.
7. Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM: Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry 2002, 51:237-252.
8. Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ: A meta-analytic study of changes in brain activation in depression. Human Brain Mapping 2008, 29:683-695.
9. Delaveau P, Jabourian M, Lemogne C, Guionnet S, Bergouignan L, Fossati P: Brain effects of antidepressants in major depression: A meta-analysis of emotional processing studies. J Affect Disord 2011, 130:66-74.
10. Sacher J, Neumann J, Funfstuck T, Soliman A, Villringer A, Schroeter ML: Mapping the depressed brain: A meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord 2011, 140:142-148.
11. Bolus NE, George R, Washington J, Newcomer BR: PET/MRI: the blended-modality choice of the future? J Nucl Med Tech 2009, 37:63-71. quiz 72-63.
12. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W264.
13. Chen R, Copeland JR, Wei L: A meta-analysis of epidemiological studies in depression of older people in the People's Republic of China. Int J Geriatr Psychiatr 1999, 14:821-830.
14. Su L, Cai Y, Wang L, Shi S: Various effects of antipsychotics on p50 sensory gating in Chinese schizophrenia patients: a meta-analysis. Psychiatria Danubina 2012, 24:44-50.
15. Chen C-H, Suckling J, Lennox BR, Ooi C, Bullmore ET: A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disorders 2011, 13:1-15.
16. Eickhoff SB, Laird AR, Grefkes C, Wang LE, Zilles K, Fox PT: Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp 2009, 30:2907-2926.
17. Diener C, Kuehner C, Brusniak W, Ubl B, Wessa M, Flor H: A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. NeuroImage 2012, 61:677-685.
18. Kurth F, Zilles K, Fox PT, Laird AR, Eickhoff SB: A link between the systems: functional differentiation and integration within the human insula revealed by meta-analysis. Brain Struct Funct 2010, 214:519-534.
19. Caspers S, Zilles K, Laird AR, Eickhoff SB: ALE meta-analysis of action observation and imitation in the human brain. NeuroImage 2010, 50:1148-1167.
20. Neumann J, von Cramon DY, Lohmann G: Model-based clustering of meta-analytic functional imaging data. Hum Brain Mapp 2008, 29:177-192.
21. Poline JB, Worsley KJ, Evans AC, Friston KJ: Combining spatial extent and peak intensity to test for activations in functional imaging. NeuroImage 1997, 5:83-96.
22. Cauda F, Geda E, Sacco K, D'Agata F, Duca S, Geminiani G, Keller R: Grey matter abnormality in autism spectrum disorder: an activation likelihood estimation meta-analysis study. J Neurol Neurosurg Psychiatr 2011, 82:1304-1313.
23. Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang S-C, Wu H-M, Au SC, Baxter LR Jr: Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatr 2001, 50:159-170.
24. Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR Jr: Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001, 58:631-640.
25. Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, Arifuzzman AI, Houle S, Vaccarino FJ: Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatr 2001, 158:899-905.
26. Kegeles LS, Malone KM, Slifstein M, Ellis SP, Xanthopoulos E, Keilp JG, Campbell C, Oquendo M, Van Heertum RL, Mann JJ: Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders. Am J Psychiatr 2003, 160:76-82.
27. Zhang Xuanhong JK, Zuo C, Cao Q, Zhao J: The analysis of regional cerebral metabolic rate of glucose in major depressive disorder with statistical parametric mapping method. Shanghai Arch Psychiatry 2005, 17:1-5.
28. Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M: HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 2007, 155:245-256.
29. Smith GS, Kramer E, Ma Y, Kingsley P, Dhawan V, Chaly T, Eidelberg D: The functional neuroanatomy of geriatric depression. Int J Geriatr Psychiatry 2009, 24:798-808.
30. WU Zhiguo FY, Bin XIE, Xiaoguang SUN, Mingle SI, Liangron WAN, Jun CHEN, Chengmei YUAN: Regional cerebral glucose metabolic abnormalities in treatment-resistant depression: a preliminary study. Chinese J Nerv Ment Dis 2009, 35:261-264.
31. Wiebking C, Bauer A, de Greck M, Duncan NW, Tempelmann C, Northoff G: Abnormal body perception and neural activity in the insula in depression: an fMRI study of the depressed "material me". World J Biol Psychiatr 2010, 11:538-549.
32. Savitz J, Nugent AC, Cannon DM, Carlson PJ, Davis R, Neumeister A, Rallis-Frutos D, Fromm S, Herscovitch P, Drevets WC: Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder. Sci Rep 2012, 2:308.
33. Martin SD, Martin E, Rai SS, Richardson MA, Royall R: Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatr 2001, 58:641-648.
34. Lai C-H, Hsu Y-Y, Wu Y-T: First episode drug-naïve major depressive disorder with panic disorder: Gray matter deficits in limbic and default network structures. Eur Neuropsychopharmacol 2010, 20:676-682.
35. van Tol MJ, van der Wee NJ, van den Heuvel OA, Nielen MM, Demenescu LR, Aleman A, Renken R, van Buchem MA, Zitman FG, Veltman DJ: Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry 2010, 67:1002-1011.
36. Beauregard M: Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Prog Neurobiol 2007, 81:218-236.
37. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, Reiss AL, Schatzberg AF: Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus. Biol Psychiatr 2007, 62:429-437.
38. Hwang JP, Lee TW, Tsai SJ, Chen TJ, Yang CH, Lirng JF, Tsai CF: Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. J Geriatr Psychiatr Neurol 2010, 23:171-184.
39. Desmond JE, Chen SH, Shieh PB: Cerebellar transcranial magnetic stimulation impairs verbal working memory. Ann Neurol 2005, 58:553-560.
40. Stuhrmann A, Suslow T, Dannlowski U: Facial emotion processing in major depression: a systematic review of neuroimaging findings. Biol Mood Anxiety Disord 2011, 1:10.
41. Baldacara L, Borgio JG, Lacerda AL, Jackowski AP: Cerebellum and psychiatric disorders. Rev Bras Psiquiatr 2008, 30:281-289.
42. Luna B, Minshew NJ, Garver KE, Lazar NA, Thulborn KR, Eddy WF, Sweeney JA: Neocortical system abnormalities in autism. Neurology 2002, 59:834-840.
43. Newberg A, Monti D, Moss A, Alavi A: Positron emission tomography in neurological and psychiatric disorders. Int J Imaging Syst Technol 2012, 22:2-17.
44. Naylor CD: Meta-analysis and the meta-epidemiology of clinical research. BMJ (Clinical research ed) 1997, 315:617-619.
45. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R: Selective publication of antidepressant trials and its influence on apparent efficacy. New Engl J Med 2008, 358:252-260.
46. Laird AR, Fox PM, Price CJ, Glahn DC, Uecker AM, Lancaster JL, Turkeltaub PE, Kochunov P, Fox PT: ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp 2005, 25:155-164.